Similar articles for PMID: 21418261

Year	Number of Results
1962	1
1989	1
1996	1
1997	2
2000	3
2001	2
2003	1
2004	9
2005	12
2006	12
2007	10
2008	24
2009	27
2010	12
2011	33
2012	39
2013	30
2014	38
2015	32
2016	21
2017	29
2018	25
2019	22
2020	27
2021	13
2022	11

1

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.

Guglielmetti S, Mora D, Gschwender M, Popp K. Guglielmetti S, et al. Aliment Pharmacol Ther. 2011 May;33(10):1123-32. doi: 10.1111/j.1365-2036.2011.04633.x. Epub 2011 Mar 21. Aliment Pharmacol Ther. 2011. PMID: 21418261 Free article. Clinical Trial.

2

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.

Andresen V, Gschossmann J, Layer P. Andresen V, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):658-666. doi: 10.1016/S2468-1253(20)30056-X. Epub 2020 Apr 8. Lancet Gastroenterol Hepatol. 2020. PMID: 32277872 Clinical Trial.

3

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG. Ki Cha B, et al. J Clin Gastroenterol. 2012 Mar;46(3):220-7. doi: 10.1097/MCG.0b013e31823712b1. J Clin Gastroenterol. 2012. PMID: 22157240 Clinical Trial.

4

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier CH, Matuchansky C. Guyonnet D, et al. Aliment Pharmacol Ther. 2007 Aug 1;26(3):475-86. doi: 10.1111/j.1365-2036.2007.03362.x. Aliment Pharmacol Ther. 2007. PMID: 17635382 Free article. Clinical Trial.

5

A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.

Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ. Choi CH, et al. J Clin Gastroenterol. 2011 Sep;45(8):679-83. doi: 10.1097/MCG.0b013e318204593e. J Clin Gastroenterol. 2011. PMID: 21301358 Clinical Trial.

6

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.

Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. Drouault-Holowacz S, et al. Gastroenterol Clin Biol. 2008 Feb;32(2):147-52. doi: 10.1016/j.gcb.2007.06.001. Epub 2008 Mar 4. Gastroenterol Clin Biol. 2008. PMID: 18387426 Free article. Clinical Trial.

7

Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.

Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R. Kajander K, et al. Aliment Pharmacol Ther. 2008 Jan 1;27(1):48-57. doi: 10.1111/j.1365-2036.2007.03542.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2008. PMID: 17919270 Free article. Clinical Trial.

8

Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG. Yoon JS, et al. J Gastroenterol Hepatol. 2014 Jan;29(1):52-9. doi: 10.1111/jgh.12322. J Gastroenterol Hepatol. 2014. PMID: 23829297 Clinical Trial.

9

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome.

Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Silk DB, et al. Aliment Pharmacol Ther. 2009 Mar 1;29(5):508-18. doi: 10.1111/j.1365-2036.2008.03911.x. Epub 2008 Dec 2. Aliment Pharmacol Ther. 2009. PMID: 19053980 Free article. Clinical Trial.

10

A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.

Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I. Urgesi R, et al. Eur Rev Med Pharmacol Sci. 2014;18(9):1344-53. Eur Rev Med Pharmacol Sci. 2014. PMID: 24867512 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed